Elevated serum uric acid independently predicts progression to cardiometabolic disease and multimorbidity, with gout serving as a clinical marker of this systemic risk. This relationship persists across metabolic phenotypes, suggesting uric acid operates as a metabolic signal warranting earlier intervention than current clinical thresholds recognize.
Key Points
- Elevated uric acid predicts cardiometabolic disease independent of gout status
- Gout presence amplifies multimorbidity risk beyond uric acid levels alone
- Risk stratification possible before symptomatic disease onset
Longevity Analysis
Uric acid functions as an interpretable signal of metabolic dysregulation that precedes overt disease. Rather than treating gout as an isolated inflammatory condition, this data frames elevated uric acid as a measurable warning of broader system dysfunction—affecting how the body produces energy, regulates circulation, and mounts inflammatory responses. Identifying this signal early allows intervention before multiple systems deteriorate into established cardiometabolic disease, a critical transition point in healthspan compression.
Original published by Nature - npj Aging, by Chuanghai Wu.